Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: Bioasis to Present at Upcoming Industry Conferences

Bioasis to Present at Upcoming Industry Conferences

https://www.bioasis.us/bioasis-to-present-at-upcoming-industry-conferences/

Jan. 6, 2020, GUILFORD, Conn. GUILFORD, Conn.–(Business Wire)– Bioasis Technologies, Inc . (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, today announced that Dr. Deborah Rathjen, Executive Chair and Chief Executive Officer of Bioasis will present at the following industry conferences:

3 rd Annual Neuroscience Innovation Forum for Business Development, Licensing and Investment. (https://www.sachsforum.com/3nif-about.html)

  • Bioasis company presentation on Sunday, January 12, 2020 at 11:25am PT in the Regimental room at the Marines’ Memorial Club & Hotel, San Francisco.
  • Rare and Orphan Diseases Panel on Sunday, January 12, 2020 at 2:10pm PT in the Commandants room.

Biotech Showcase TM . (https://informaconnect.com/biotech-showcase/)

  • Bioasis company presentation on Monday, January 13, 2020 at 9:00am PT in the Franciscan A room, Ballroom level, at the Hilton San Francisco Union Square, San Francisco.
  • Bioasis company presentation will be followed at 11:20am PT on Monday, January 13, 2020 by an interview with Proactive Investors.

Follow us on:

Share
New Message
Please login to post a reply